ASH | FDA Collaboration: A Workshop on Regulatory Science in Hematology – Hematology.org
ASH | FDA Collaboration: A Workshop on Regulatory Science in Hematology
ASH | FDA Collaboration: A Workshop on Regulatory Science in Hematology
You do not need to spend five figures to learn what matters for a longer, healthier life.
Louise Levy, 112, was part of a subset of Ashkenazi Jews with astonishing cognitive abilities who are being studied by longevity researchers.
AbstractBackgroundThe glucagon-like peptide-1 receptor agonist, semaglutide, improved health status and reduced body weight in patients with obesity-related heart failure (HF) with preserved ejecti…
AbstractBackgroundThe glucagon-like peptide-1 receptor agonist, semaglutide, improved health status and reduced body weight in patients with obesity-related heart failure (HF) with preserved ejecti…
Join us live from the Heart Failure Association (HFA) meeting 2024, for an exclusive discussion between Prof Giuseppe Rosano (St George’s Hospital, London, UK), Dr…
I am a myeloma doctor that is passionate about quality of life, less is more approaches, supportive care and evidenced based medicine. Philantrophy is what…
The current situation regarding fear of cancer recurrence (FCR) is “not optimistic” in patients who have undergone surgery for gastric cancer, according to a recent…
I’ve been affiliated with The Leukemia & Lymphoma Society (LLS) for many years through the volunteer/fundraising opportunities available to my kids. Little did I know…
Myelofibrosis (MF) is a rare blood cancer that leads to scarring in the bone marrow, which alters the normal production of blood cells. Get the…